Patent · US Active

NKp46 binding proteins

US10519234B2 · kind B2 · utility

5Cited by
18References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 2015
Grant dateDec 31, 2019
Priority date—
Expiry dateApr 21, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Multispecific proteins that bind and specifically redirect NK cells to lyse a target cell of interest are provided without non-specific activation of NK cells in absence of target cells. The proteins have utility in the treatment of disease, notably cancer or infectious disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.